InvestorsHub Logo
Followers 120
Posts 9122
Boards Moderated 0
Alias Born 07/17/2005

Re: whytestocks post# 142160

Wednesday, 07/22/2020 1:32:27 PM

Wednesday, July 22, 2020 1:32:27 PM

Post# of 163971
Wow! Wonderful news. RXAir 400 Germicidal Ultraviolet (UV-C) light air purification system.

Worcester, MA, July 22, 2020 (GLOBE NEWSWIRE) -- With heightened concern about protection from harmful airborne viruses, Vystar Corporation’s (OTCQB: VYST) RxAir®400 Germicidal Ultraviolet (UV-C) light air purification systems offers new features and options that will make it easier to treat airborne pathogens wherever you go indoors. RxAir400 is a smaller, consumer/small business-sized version of the industrial size Rx3000 FDA-certified Class II medical device UV light air purifier designed for disinfection use in hospitals. RxAir400 will now feature an ergonomic integrated handle for easier room-to-room portability, plus offer two new accessory options:

Extended Life 18,000 Hour RxAir400 UV-C Pro bulb replacement cartridge - UV bulbs have limited life for germicidal effectiveness. RxAir units and bulb cartridges have interactive chips that communicate to alert users as the bulb approaches the end of life and needs to be replaced. RxAir 400 comes with its standard 9000 hr. UVC bulb cartridge good for approximately one year of regular use before requiring replacement. The new UVC Pro replacement cartridge has a lifespan of 18,000 hours, or approximately two years of normal use. Cartridges include free return and disposal of spent cartridges.
Wall mount bracket – New low profile wall mount bracket makes it easier to put RxAir in an optimal location when traffic patterns and furniture layout are not conducive to floor placement. The low profile bracket allows you to easily lift unit off the bracket to transport room to room to safely inactivate >99.9% of pathogens, reducing virus exposure risk in occupied facilities such as schools, restaurants, retail and offices.
Vystar is currently taking pre-orders on its RxAir.com website for new units, replacement bulb cartridges and wall mount brackets expected to be in stock in mid- to late August – just in time as students head back to school.

“A main advantage of RxAir is that it can operate safely in occupied spaces to continuously process the air up to eight times per hour, inactivating or killing the pathogens expelled as people talk, breathe, cough, sneeze or sing to help reduce risk of exposure for those in the room,” stated Bryan Stone, MD, Internal Medicine and Nephrology, and Chief of Medicine for Desert Regional Medical Center. “When near people who aren’t wearing masks and may be asymptomatic, it is reassuring to have RxAir treating pathogens they may be expelling.”

“Given the growing body of evidence that Coronavirus SARS CoV-2 may be transmitted through airborne means or aerosolization noted by the CDC1,2, and hundreds of scientists worldwide3,4,5, it is wise to address all modes of possible transmission,” Dr. Stone noted. “We strongly encourage people to wear face masks and follow other CDC recommended surface and personal disinfection practices, along with using RxAir to decrease their pathogen exposure risk as much as possible.”

“RxAir400’s ViraTech technology is one of the few UV light air purification technologies proven in EPA- and FDA-certified laboratory testing to inactivate more than 99.9% of airborne viruses (including multiple coronavirus strains), bacteria and other pathogens that cause pneumonia, influenza, MRSA (staph), streptococcus (strep throat), whooping cough, tuberculosis (TB), common cold, measles and a myriad of other antibiotic-resistant and viral infections,” Dr. Stone explained. “Hospitals and Healthcare facilities have been using ultraviolet germicidal irradiation (UVGI) with UV-C light for airborne infection control for decades because it is so effective. It also reduces concentration of volatile organic compounds and odors as well as air pollution linked to sleep disorders.”
(See RxAir video:
)

Wladyslaw Kowalski, PhD, PE, is one of the world’s foremost experts on air cleaning design and construction, indoor air quality issues, including mold and bacterial contamination and hospital infection control. Dr. Kowalski authored numerous research papers and did testing analysis for the ViraTech technology used in the RxAir product line. His research and analysis of test results are available upon request.6, 7, 8. Additionally, Dr. Kowalski, independent of RxAir, along with Thomas J. Walsh and Vidmantas Petraitis, both of the Weill Cornell Medical College of Cornell University, have published a technical report titled “2020 COVID-19 Coronavirus Ultraviolet Susceptibility” which further details the impact of UV light on COVID-19.9

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYST News